SPINEMarketGroup

Spine Industry News

SPINEMarketGroup

From Niche to Momentum: The Rapid Rise of Spinal Endoscopy — A Brief Market Update

By

With ESUBE's second masterclass taking place tomorrow (February 26–28, 2026), in Seville, Spain, it's worth looking at just how much spinal endoscopy has evolved. More hospitals are adopting these techniques, and there's been significant investment in research, what was once a highly specialized procedure is gradually becoming more routine in spine surgery. In this brief … [Read more...] about From Niche to Momentum: The Rapid Rise of Spinal Endoscopy — A Brief Market Update

ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results

By

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2025, and business highlights. Fourth Quarter and Full-Year 2025 Financial Results Fourth … [Read more...] about ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results

Arthrex

By

Arthrex is emerging as a noteworthy player in spinal endoscopy, leveraging its strong heritage in minimally invasive orthopedics and surgeon education. While not traditionally viewed as a core spine implant leader, the company is strategically expanding its endoscopic spine portfolio, focusing on tissue-sparing techniques and outpatient-friendly procedures. About … [Read more...] about Arthrex

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

By

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025: Full Year 2025: “Momentum built throughout 2025 accelerated in the fourth quarter, capping off a strong finish … [Read more...] about Globus Medical Reports Fourth Quarter and Full Year 2025 Results

We are proud to announce that A-Spine will once again be a sponsor of SPINEMarketGroup in 2026

By

Thank you, A-SPINE! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About A-SPINE The leading spine medical device brand in Taiwan A-SPINE Asia Co., Ltd. (A-SPINE) was founded in 2001. It is the first company in Taiwan … [Read more...] about We are proud to announce that A-Spine will once again be a sponsor of SPINEMarketGroup in 2026

Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

By

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2025, provided full-year 2026 financial guidance and updated its three-year financial targets. All pro forma measures contained within this release exclude the impact of … [Read more...] about Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

Zimbabwe’s First Public Endoscopic Spine Case Marks Early Progress

By

Parirenyatwa Group of Hospitals has successfully performed Zimbabwe’s first minimally invasive endoscopic spine decompression within the public healthcare system, a major breakthrough for spine treatment in Zimbabwe. The procedure, led by neurologist Serge Eddy Teneku Mba, treated a patient with complex three-level spinal stenosis who was discharged just one day after … [Read more...] about Zimbabwe’s First Public Endoscopic Spine Case Marks Early Progress

NGMedical Reports Successful 2025 and Sales Milestone for Move®-C

By

NGMedical GmbH, a leading innovator in spinal motion preservation technology, reports significant growth in 2025 NONNWEILER, SAARLAND, GERMANY, February 23, 2026 /EINPresswire.com/ -- NGMedical reports another year of double-digit growth. In 2025 revenue grew 43 % above the previous year after 90 % growth in 2024. The biggest contribution to the successful development is … [Read more...] about NGMedical Reports Successful 2025 and Sales Milestone for Move®-C

DePuy Synthes for Sale: Who Could Actually Buy the Orthopedic Giant?

By

J&J dropped the news yesterday that they're looking into selling off DePuy Synthes. Honestly, we've been calling this move ever since the spin-off wrapped up. But here's what everyone in the industry is really wondering about: Who could realistically buy an asset of this size and complexity? A rare… and complicated opportunity DePuy Synthes remains one of the leading … [Read more...] about DePuy Synthes for Sale: Who Could Actually Buy the Orthopedic Giant?

Johnson & Johnson Explores Potential $20B Sale of DePuy Synthes

By

Johnson & Johnson is preparing a potential sale of its orthopedics unit, DePuy Synthes, in a transaction that could exceed $20 billion, according to a source cited by Reuters. The company is said to be positioning private equity firms as the most likely buyers, although it has not publicly commented on the report. Last year, J&J announced plans to separate the … [Read more...] about Johnson & Johnson Explores Potential $20B Sale of DePuy Synthes

We are proud to announce that Syntropiq will once again be a sponsor of SPINEMarketGroup in 2026

By

Thank you, Syntropiq! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About Syntropiq We are a privately held spine interbody implant and surface technology company. Our team members with rich experience more than 25 … [Read more...] about We are proud to announce that Syntropiq will once again be a sponsor of SPINEMarketGroup in 2026

Modern Leadership: Lots of light. Little reality

By

Emmanuel Badet--We renamed the management. We made it up, modernized it, dressed it up in seductive words. However, behind this contemporary veneer, many organizations still operate as they did yesterday, simply with more slides, more anglicisms and much more human fatigueLet's be clear-headed. Management sometimes resembles a shadow theatre. We talk about vision, autonomy, … [Read more...] about Modern Leadership: Lots of light. Little reality

Dymicron Appoints Veteran MedTech CEO Peter Wehrly to Board of Directors

By

Global C-suite leader brings decades of spinal innovation and PMA experience to support Dymicron's next stage of growth OREM, Utah, Feb. 19, 2026 /PRNewswire/ -- Dymicron®, a privately held medical device company advancing next-generation spinal motion-preservation technology, today announced the appointment of Peter Wehrly, one of the spinal industry's most … [Read more...] about Dymicron Appoints Veteran MedTech CEO Peter Wehrly to Board of Directors

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

By

The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the first personalized cervical plating procedure using the corra™ Cervical Plating System, the latest addition to its portfolio of personalized … [Read more...] about Carlsmed Announces first corra™ personalized Cervical Plating Procedure

FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether

By

Motion-Preserving Lumbar Spine Surgery - Stabilization Without Fusion for Patients with Degenerative Spondylolisthesis SAN CARLOS, Calif., February 18, 2026 (Newswire.com) - The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex™ Dynamic Sagittal Tether, a motion-preserving system for the treatment of lumbar spinal … [Read more...] about FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether

Spineway : 2025 annual results

By

Ecully, February 17, 2026, SPINEWAY 2025 annual results: * 2024 Pro forma: changes to the 2025 French General Chart of Accounts (ANC Regulation 2022-06) required the inclusion in operating income/(loss) of items that were previously recognized in exceptional income and expenses. Additionally, the Research and Innovation tax credits, which were recognized in operating … [Read more...] about Spineway : 2025 annual results

Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology

By

SAN LUIS OBISPO, Calif., Feb. 18, 2026 /PRNewswire/ -- Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced that the Company has surpassed treating one million patients worldwide across its product portfolio over the … [Read more...] about Fziomed Commemorates One Millionth Patient Treated With Its Dual-Polymer Adhesion Barrier Technology

Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters

By

GALWAY, Ireland, Feb. 17, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its third quarter (Q3) of fiscal year 2026 (FY26), which ended January 23, 2026. Q3 Key Highlights "Q3 marks another strong quarter, delivering 6% organic revenue growth, ahead of guidance, demonstrating the strength … [Read more...] about Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters